Technological watch
Packaging manufacturer Sanner acquires Springboard
Sanner Group, a healthcare packaging manufacturer and medical device Contract Development and Manufacturing Organisation (CDMO) has acquired Springboard, a specialist in the design and development of medical devices for regulated markets.
× 3rdtimeluckystudio / shutterstock
2169442005 Deal concept
The acquisition of Springboard is in line with Sanner Group’s goal to build a suite of services for its customers across the drug delivery, diagnostic and medtech device sectors. Springboard’s capabilities will boost Sanner Group’s in-house medical device development capabilities and see the establishment of a new Design Centre of Excellence in the UK.
Hans-Willem van Vliet, CEO of Sanner Group, said: “Sanner Group has transformed from a market leader in desiccant closures and effervescent tablet packaging, to a sought-after provider of customer-specific solutions in the fields of medical technology, diagnostics, pharmaceuticals, and consumer healthcare. The acquisition of Springboard further strengthens this offering, giving our customers deep expertise and support across the entire medical device development process, from initial concept design to commercial manufacturing.
“Springboard’s strong reputation for delivering exceptional concept through to manufacture design services, along with its ability to solve complex technical and scientific problems for its customers combined with an excellent culture, make this a highly complementary acquisition. We very much look forward to welcoming the Springboard team to the Sanner Group and delivering excellence at all stages of the product lifecycle.”
Springboard develops devices from an initial concept through to manufacture with a full suite of engineering, multidisciplinary scientific skills and engineering capabilities, delivering a full service for both pre- and post-product launch. The 30-strong company, with in-house capabilities such as physics, electronics, software, and materials science, is known for cost-effective regulated device development that delivers valuable intellectual property for customers. Springboard’s expertise spans across drug delivery devices, such as autoinjectors, infusion pumps, inhalers and syringes, and equipment and consumables in the fields of respiratory, surgical, critical care, implantables, diagnostics and biotechnology.
Sanner Group is building a next generation device-CDMO that combines agility and smart thinking with a long tradition in the active primary healthcare packaging sector, including the world’s largest portfolio of effervescent products. The acquisition of Springboard is an important part of Sanner Group’s strategy to enhance its CDMO activities in the medical technology and diagnostics arena. Sanner Group’s new Design Centre of Excellence will be at the core of this.
Tom Oakley, director of Springboard, said: “We are excited to join Sanner Group to form its Design Centre of Excellence for medical device development. Our clients, from the largest multinational companies to the fastest growing start-ups, will not only be able to access design innovation based on first class scientific and engineering capabilities, but also benefit from integrated design for manufacturing. We can support every project from small-scale production for verification and clinical trials to full-scale serial production within the Sanner Group’s global manufacturing facilities.”
Keith Turner, director of Springboard, added: “Our combination with Sanner Group brings world-class intelligent healthcare solutions to our clients, and is a major step in our growth journey. Sanner and Springboard have a shared commitment to improve people’s lives around the world and we are excited to be pursuing this objective together.”
Sanner Group was advised by Alvarez & Marsal as financial advisors and Deloitte as tax structuring advisors with Norton Rose Fulbright acting as legal advisor.
Back to Search Results Tags Sanner Springboard Top Stories Packaging Contract manufacturing drug delivery Diagnostics medical technology
× 3rdtimeluckystudio / shutterstock
2169442005 Deal concept
The acquisition of Springboard is in line with Sanner Group’s goal to build a suite of services for its customers across the drug delivery, diagnostic and medtech device sectors. Springboard’s capabilities will boost Sanner Group’s in-house medical device development capabilities and see the establishment of a new Design Centre of Excellence in the UK.
Hans-Willem van Vliet, CEO of Sanner Group, said: “Sanner Group has transformed from a market leader in desiccant closures and effervescent tablet packaging, to a sought-after provider of customer-specific solutions in the fields of medical technology, diagnostics, pharmaceuticals, and consumer healthcare. The acquisition of Springboard further strengthens this offering, giving our customers deep expertise and support across the entire medical device development process, from initial concept design to commercial manufacturing.
“Springboard’s strong reputation for delivering exceptional concept through to manufacture design services, along with its ability to solve complex technical and scientific problems for its customers combined with an excellent culture, make this a highly complementary acquisition. We very much look forward to welcoming the Springboard team to the Sanner Group and delivering excellence at all stages of the product lifecycle.”
Springboard develops devices from an initial concept through to manufacture with a full suite of engineering, multidisciplinary scientific skills and engineering capabilities, delivering a full service for both pre- and post-product launch. The 30-strong company, with in-house capabilities such as physics, electronics, software, and materials science, is known for cost-effective regulated device development that delivers valuable intellectual property for customers. Springboard’s expertise spans across drug delivery devices, such as autoinjectors, infusion pumps, inhalers and syringes, and equipment and consumables in the fields of respiratory, surgical, critical care, implantables, diagnostics and biotechnology.
Sanner Group is building a next generation device-CDMO that combines agility and smart thinking with a long tradition in the active primary healthcare packaging sector, including the world’s largest portfolio of effervescent products. The acquisition of Springboard is an important part of Sanner Group’s strategy to enhance its CDMO activities in the medical technology and diagnostics arena. Sanner Group’s new Design Centre of Excellence will be at the core of this.
Tom Oakley, director of Springboard, said: “We are excited to join Sanner Group to form its Design Centre of Excellence for medical device development. Our clients, from the largest multinational companies to the fastest growing start-ups, will not only be able to access design innovation based on first class scientific and engineering capabilities, but also benefit from integrated design for manufacturing. We can support every project from small-scale production for verification and clinical trials to full-scale serial production within the Sanner Group’s global manufacturing facilities.”
Keith Turner, director of Springboard, added: “Our combination with Sanner Group brings world-class intelligent healthcare solutions to our clients, and is a major step in our growth journey. Sanner and Springboard have a shared commitment to improve people’s lives around the world and we are excited to be pursuing this objective together.”
Sanner Group was advised by Alvarez & Marsal as financial advisors and Deloitte as tax structuring advisors with Norton Rose Fulbright acting as legal advisor.
Back to Search Results Tags Sanner Springboard Top Stories Packaging Contract manufacturing drug delivery Diagnostics medical technology
This project has received funding from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 837761.
